MarketPulse
O

$ORXOY

2 articles found
1 positive
0 negative
1 neutral
BenzingaBenzinga··Prnewswire

Orexo Charts New Course with R&D Day Showcase of AmorphOX Pipeline

Orexo invites investors to March 24 R&D Day in Stockholm to present post-Zubsolv strategy, featuring AmorphOX technology and pipeline programs OX640 and OX390.
ORXOYpipelinestrategic priorities
BenzingaBenzinga··Prnewswire

Orexo Restructures Leadership to Pivot Toward Drug Development After Zubsolv Sale

Orexo restructures leadership and divests Zubsolv to focus on drug development and AmorphOX technology advancement.
ORXOYproduct developmentorganizational restructuring